H7N9 influenza virus split vaccine (Hualan Biological Bacterin)

H7N9流感病毒裂解疫苗（华兰生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH7N9 influenza virus split vaccine (Hualan Biological Bacterin)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesHualan Biological Bacterin Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHualan Biological Bacterin Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza A virus infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A